PRELIMINARY RESULTS OF TOTAL NEOADJUVANT THERAPY IN STAGE II–III RECTAL CANCER: REAL-WORLD DATA FROM K HOSPITAL
.
Tóm tắt
.
Abstract
Background: Total Neoadjuvant Therapy (TNT) has recently emerged as a promising approach in the management of locally advanced rectal cancer. However, real-world evidence on its effectiveness and safety in Vietnam remains limited.
Methods: We retrospectively analyzed 148 patients with stage II–III rectal cancer of the middle or lower rectum treated with TNT at K Hospital. TNT regimens included chemotherapy combined with either short-course or long-course chemoradiation therapy. Surgery was performed 4–8 weeks after completion of TNT. Treatment outcomes, pathological response, sphincter preservation, and adverse events were assessed.
Results: The mean age was 57.2 years, with a male-to-female ratio of 1.96:1. Tumor downstaging was achieved in 68.9% of patients with a pathological complete response (pCR) rate of 25.7% and sphincter preservation rate of 71.6%. Peripheral neuropathy and elevated AST were the most common adverse events. Grade 3–4 toxicities most frequently included neutropenia (8.1%) and diarrhea (4.1%). Multivariate analysis revealed that earlier tumor stage and the use of triplet chemotherapy regimens were significantly associated with higher pCR rates.
Conclusions: Total neoadjuvant therapy (TNT) was well tolerated in this cohort and was associated with favorable pathological response in patients with stage II–III rectal cancer. Further prospective studies are warranted to confirm these findings and optimize treatment strategies in the Vietnamese setting.
Từ khóa
.
Keywords
Rectal cancer; Total neoadjuvant therapy (TNT); pathological complete response (pCR).
Tài liệu tham khảo (References)
- Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229-263. doi:10.3322/caac.21834
- Bahadoer RR, Dijkstra EA, Etten B van, Marijnen CAM, Putter H, Kranenbarg EMK, Roodvoets AGH, Nagtegaal ID, Beets-Tan RGH, Blomqvist LK, Fokstuen T, Tije AJT, Crolla RMPH, Luijtgaarden ACM van de, Dekker JWT, Capdevila J, et al. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. The Lancet Oncology. 2021;22(1):29-42. doi:10.1016/S1470-2045(20)30555-6
- Conroy T, Bosset JF, Etienne PL, Rio E, François É, Mesgouez-Nebout N, Vendrely V, Artignan X, Vautravers C, Abdelghani MB, Aparicio T, Desot E, Marquis I. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial. The Lancet Oncology. 2021;22(5):702-715. doi:10.1016/S1470-2045(21)00079-6
- Hoàng NH, Biểu BQ, Thăng VH. 18. Kết quả bước đầu hóa xạ trị đồng thời kết hợp hóa trị bổ trợ trước phẫu thuật bệnh nhân ung thư trực tràng giai đoạn II, III. TCNCYH. 2024;179(6):166-174. doi:10.52852/tcncyh.v179i6.2489
- Giang DTT, Thăng VH, Phương NTM, Phúc PĐ, Long TN, Tâm ĐH, Phong VQ. Kết quả điều trị tân bổ trợ toàn bộ ở bệnh nhân ung thư trực tràng giai đoạn II, III tại Bệnh viện Trung ương Quân đội 108. Journal of 108 - Clinical Medicine and Phamarcy. Published online November 5, 2024. doi:10.52389/ydls.v19i6.2384
- Đăng NV, Nhung TTP. Kết quả bước đầu liệu pháp tân bổ trợ toàn phần trên bệnh nhân ung thư trực tràng giai đoạn II, III tại Bệnh viện K. TCNCYH. 2025;186(1):234-242. doi:10.52852/tcncyh.v186i1.2721
- Hùng NV, Tân NN, Mạnh PD, Bách TT, Linh DT, Hoan PT, Dũng TN, Huy TL. Kết quả bước đầu điều trị tân bổ trợ toàn phần bệnh nhân ung thư trực tràng xâm lấn tại chỗ tại vùng. TCNCYH. 2024;185(12):44-51. doi:10.52852/tcncyh.v185i12.2790
- Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Prz Gastroenterol. 2019;14(2):89-103. doi:10.5114/pg.2018.81072
- Glover M, Mansoor E, Panhwar M, Parasa S, Cooper GS. Epidemiology of Colorectal Cancer in Average Risk Adults 20-39 Years of Age: A Population Based National Study. Dig Dis Sci. 2019;64(12):3602-3609. doi:10.1007/s10620-019-05690-8
- Dijkstra EA, Nilsson PJ, Hospers GAP, Bahadoer RR, Meershoek-Klein Kranenbarg E, Roodvoets AGH, Putter H, Berglund Å, Cervantes A, Crolla RMPH, Hendriks MP, Capdevila J, Edhemovic I, Marijnen CAM, van de Velde CJH, Glimelius B, van Etten B, Collaborative Investigators. Locoregional Failure During and After Short-course Radiotherapy Followed by Chemotherapy and Surgery Compared With Long-course Chemoradiotherapy and Surgery: A 5-Year Follow-up of the RAPIDO Trial. Ann Surg. 2023;278(4):e766-e772. doi:10.1097/SLA.0000000000005799
